REPORT ID 6855

Global Insomnia Therapy Market Research Report 2017

Publish Date
1-Nov-17
Pages
115
Format
Electronic (PDF)

In this report, the global Insomnia Therapy market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Insomnia Therapy in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Insomnia Therapy market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Merck & Co. Inc.
    Sanofi
    Pfizer, Inc.
    Takeda Pharmaceutical Company Ltd.
    Purdue Pharmaceuticals L.P.
    Eisai, Co. Ltd.
    Meda Consumer Healthcare Inc.
    Pernix Therapeutics
    Vanda Pharmaceuticals
    ECR Pharmaceuticals
    Fidia Farmaceutici
    Dainippon Sumitomo
    Biocodex
    Eli Lilly and Company
    Ebb Therapeutics
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Non-pharmacological Therapy
    Pharmacological Therapy
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Hospital
    Ambulatory Surgical Center
    Home Care

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Insomnia Therapy Market Research Report 2017
1 Insomnia Therapy Market Overview
    1.1 Product Overview and Scope of Insomnia Therapy
    1.2 Insomnia Therapy Segment by Type (Product Category)
        1.2.1 Global Insomnia Therapy Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Insomnia Therapy Production Market Share by Type (Product Category) in 2016
        1.2.3 Non-pharmacological Therapy
        1.2.4 Pharmacological Therapy
    1.3 Global Insomnia Therapy Segment by Application
        1.3.1 Insomnia Therapy Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Hospital
        1.3.3 Ambulatory Surgical Center
        1.3.4 Home Care
    1.4 Global Insomnia Therapy Market by Region (2012-2022)
        1.4.1 Global Insomnia Therapy Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Insomnia Therapy (2012-2022)
        1.5.1 Global Insomnia Therapy Revenue Status and Outlook (2012-2022)
        1.5.2 Global Insomnia Therapy Capacity, Production Status and Outlook (2012-2022)

2 Global Insomnia Therapy Market Competition by Manufacturers
    2.1 Global Insomnia Therapy Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Insomnia Therapy Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Insomnia Therapy Production and Share by Manufacturers (2012-2017)
    2.2 Global Insomnia Therapy Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Insomnia Therapy Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Insomnia Therapy Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Insomnia Therapy Market Competitive Situation and Trends
        2.5.1 Insomnia Therapy Market Concentration Rate
        2.5.2 Insomnia Therapy Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Insomnia Therapy Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Insomnia Therapy Capacity and Market Share by Region (2012-2017)
    3.2 Global Insomnia Therapy Production and Market Share by Region (2012-2017)
    3.3 Global Insomnia Therapy Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Insomnia Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Insomnia Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Insomnia Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Insomnia Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Insomnia Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Insomnia Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Insomnia Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Insomnia Therapy Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Insomnia Therapy Consumption by Region (2012-2017)
    4.2 North America Insomnia Therapy Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Insomnia Therapy Production, Consumption, Export, Import (2012-2017)
    4.4 China Insomnia Therapy Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Insomnia Therapy Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Insomnia Therapy Production, Consumption, Export, Import (2012-2017)
    4.7 India Insomnia Therapy Production, Consumption, Export, Import (2012-2017)

5 Global Insomnia Therapy Production, Revenue (Value), Price Trend by Type
    5.1 Global Insomnia Therapy Production and Market Share by Type (2012-2017)
    5.2 Global Insomnia Therapy Revenue and Market Share by Type (2012-2017)
    5.3 Global Insomnia Therapy Price by Type (2012-2017)
    5.4 Global Insomnia Therapy Production Growth by Type (2012-2017)

6 Global Insomnia Therapy Market Analysis by Application
    6.1 Global Insomnia Therapy Consumption and Market Share by Application (2012-2017)
    6.2 Global Insomnia Therapy Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Insomnia Therapy Manufacturers Profiles/Analysis
    7.1 Merck & Co. Inc.
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Insomnia Therapy Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Merck & Co. Inc. Insomnia Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Sanofi
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Insomnia Therapy Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Sanofi Insomnia Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Pfizer, Inc.
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Insomnia Therapy Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Pfizer, Inc. Insomnia Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Takeda Pharmaceutical Company Ltd.
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Insomnia Therapy Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Purdue Pharmaceuticals L.P.
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Insomnia Therapy Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Eisai, Co. Ltd.
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Insomnia Therapy Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Eisai, Co. Ltd. Insomnia Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Meda Consumer Healthcare Inc.
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Insomnia Therapy Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Meda Consumer Healthcare Inc. Insomnia Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Pernix Therapeutics
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Insomnia Therapy Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Pernix Therapeutics Insomnia Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Vanda Pharmaceuticals
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Insomnia Therapy Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Vanda Pharmaceuticals Insomnia Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 ECR Pharmaceuticals
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Insomnia Therapy Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 ECR Pharmaceuticals Insomnia Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 Fidia Farmaceutici
    7.12 Dainippon Sumitomo
    7.13 Biocodex
    7.14 Eli Lilly and Company
    7.15 Ebb Therapeutics

8 Insomnia Therapy Manufacturing Cost Analysis
    8.1 Insomnia Therapy Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Insomnia Therapy

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Insomnia Therapy Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Insomnia Therapy Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Insomnia Therapy Market Forecast (2017-2022)
    12.1 Global Insomnia Therapy Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Insomnia Therapy Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Insomnia Therapy Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Insomnia Therapy Price and Trend Forecast (2017-2022)
    12.2 Global Insomnia Therapy Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Insomnia Therapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Insomnia Therapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Insomnia Therapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Insomnia Therapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Insomnia Therapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Insomnia Therapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Insomnia Therapy Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Insomnia Therapy Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer